MRI correlates of disability progression in patients with CIS over 48 months

Tomas Uher, Dana Horakova, Niels Bergsland, Michaela Tyblova, Deepa P. Ramasamy, Zdenek Seidl, Manuela Vaneckova, Jan Krasensky, Eva Havrdova, Robert Zivadinov

Research output: Contribution to journalArticlepeer-review


Background Gray matter (GM) and white matter (WM) pathology has an important role in disease progression of multiple sclerosis (MS). Objectives To investigate the association between the development of GM and WM pathology and clinical disease progression in patients with clinically isolated syndrome (CIS). Methods This prospective, observational, 48-month follow-up study examined 210 CIS patients treated with 30 μg of intramuscular interferon beta-1a once a week. MRI and clinical assessments were performed at baseline, 6, 12, 24, 36 and 48 months. Associations between clinical worsening [24-weeks sustained disability progression (SDP) and occurrence of a second clinical attack] and longitudinal changes in lesion accumulation and brain atrophy progression were investigated by a mixed-effect model analysis after correction for multiple comparisons. Results SDP was observed in 32 (15.2%) CIS patients, while 146 (69.5%) were stable and 32 (15.2%) showed sustained disability improvement. 112 CIS patients (53.3%) developed clinically definite MS (CDMS). CIS patients who developed SDP showed increased lateral ventricle volume (p

Original languageEnglish
Pages (from-to)312-319
Number of pages8
JournalNeuroImage: Clinical
Publication statusPublished - 2014


  • Atrophy
  • Clinically isolated syndrome
  • Gray matter
  • Lesions
  • Longitudinal
  • MRI
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Cognitive Neuroscience
  • Neurology
  • Medicine(all)


Dive into the research topics of 'MRI correlates of disability progression in patients with CIS over 48 months'. Together they form a unique fingerprint.

Cite this